The majority of patients with epilepsy live in developing countries but there is limited information on status epilepticus (SE) from these regions. We evaluated the clinical profile and predictors of poor outcome in a group of Chinese patients with SE. Patients with SE were ascertained from the medical, intensive care and emergency departments of a large urban hospital from 1996 to 2001. Factors for poor outcome, defined as death or morbidity as measured by deterioration in functional status using the Glasgow Outcome Score were analysed in a multivariate logistic regression model. A total of 107 episodes of SE occurring in Chinese patients were studied. The three most common underlying causes were cerebrovascular disease, metabolic derangement and anti-convulsant withdrawal but alcohol-related SE was infrequent. Twenty-six percent had worsened functional ability and the mortality rate was 16%. Predictors of poor outcome were older age (odds ratio (OR) = 1.04, 95% CI 1.01-1.07), delay in treatment (OR = 3.52, 95%CI 1.01-12.18), SE due to cerebrovascular disease (OR = 9.73, 95% CI 1.58-59.96) and CNS infection (OR = 30.27, 95% CI 3.14-292.19).
INTRODUCTION
Status epilepticus (SE) is the result of a variety of insults to the central nervous system and is a common neurological emergency 1 . An estimated 5-61 patients per 100 000 residents develop SE in the United States and Western Europe every year [2] [3] [4] [5] [6] . Age, seizure type, aetiology, female sex, duration of SE and time elapsed from onset to treatment have been reported as prognostic factors [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . So far no clinical study of this condition in Chinese adults has been reported. We investigated the demographic data, clinical features and aetiology among patients who were admitted with SE to an urban Chinese hospital as well as independent factors for poor outcome.
METHODS
We collected data from consecutive patients over 12 years old who were admitted with SE to the Prince of Wales Hospital in Hong Kong, China. This is the only government acute hospital in the district in which it serves; locally less than 2% of patients with epilepsy-related hospitalisations are admitted to private institutions 13 . We performed a retrospective search of patients from January 1996 to December 1999; from January 2000 to December 2001, we prospectively included cases admitted with a diagnosis of SE. Patients were identified from the records of the electrodiagnostic unit and from the hospital's computerised information system recording the admission/discharge records of the emergency and medical departments and the intensive care unit (ICU). (International Classification of Disease (ICD)-9 codes 345.2, 345.3, 345.7 and 780.39.) SE was defined as (1) continuous seizure activity lasting 30 minutes or more or (2) recurrent seizure activity lasting 30 minutes or more without full return of consciousness.
After establishing that the criteria for the diagnosis of SE was satisfied, the following information was recorded using a standardised data sheet: demograhic details, history of co-existing medical diseases, history of epilepsy and anti-epileptic drug use, seizure type, aetiology, results of laboratory, brain imaging and electroencephalography (EEG) investigations, duration of ICU stay and outcome. All patient files and records were reviewed by two study physicians. Seizure types were categorised according to the International Classification of Epileptic Seizures based on scrutiny of case notes in patients ascertained retrospectively and on information from witnesses, nursing and physician staff in patients in the prospective group 14 . The episodes were classified as overt generalised convulsive, non-convulsive, partial motor and myoclonic SE. EEG confirmation was needed to diagnose non-convulsive status epilepticus (NCSE). Non-compliance with anti-epileptic drugs required laboratory or historical support. Patients who did not meet the definition of SE were excluded. Aetiology was defined as the presence of a remote or acute symptomatic injury that was assumed to have caused the episode, following the modified classification of Hauser and Kurland 15 . Similar to previous studies, etiologic causes were categorised as alcohol-related, anti-epileptic drug non-compliance, cerebrovascular disease, central nervous system infection, toxic-metabolic disorders, trauma and tumours. If there was no clinical, laboratory or radiological evidence sufficient to support a specific cause, the aetiology was labelled as idiopathic.
All patients were treated according to established hospital management guidelines, based on published recommendations with intravenous diazepam or lorazepam followed by phenytoin loading of 15-20 mg/kg as first line anti-convulsive therapy 16 . Second-line agents were not standardised and consisted of midazolam, propofol, phenobarbitone or thiopentone infusions. Delay in treatment was defined here as initiation of anti-epileptic drugs (AED) 30 minutes after the onset of SE as reported by witnesses or medical personnel. Patients with recurrent or continuous seizures for over 60 minutes despite adequate therapy in accordance with the protocol were regarded as being in refractory SE.
Functional status as defined by the Glasgow Outcome Score (GOS) was recorded in all patients at the time of discharge 17 . This widely used scoring system consists of five degrees of handicap (GOS): (1) death within the first month; (2) vegetative state; (3) severe disability-conscious but requiring constant supervision; (4) moderate disability-neurological impairment, but independent; (5) good recovery (leading an independent life, with or without minimal neurological impairment). Poor outcome was defined as death or functional deterioration of one or more points on the GOS among survivors at discharge as compared with pre-admission.
Statistical analysis
All data were analysed with SPSS 9.0 software for Windows (Chicago, IL). In the univariate analysis, age was analysed as a continuous variable, and the presence of pre-existing epilepsy, seizure type, aetiology and delay in treatment were analysed as categorical variables. Independent t-test or one-way ANOVA was used for continuous variables and chi-squared or Fisher's exact test for categorical variables. The predictive factors for poor outcome were determined in the multivariate logistic regression model after adjustment for age, gender, pre-existing epilepsy, seizure type, delay in treatment and aetiology. Statistic significance was regarded at the 0.05 level.
RESULTS
A total of 115 episodes of SE were identified of which 107 fulfilled the entry criteria; one patient had two episodes of SE. Eight were excluded because of the final diagnosis of psychogenic seizures, duration of seizure under 30 minutes (two cases each) and misclassification (four cases). The demographic details, seizure types and outcomes were similar in both the retrospective and prospective groups and, therefore, the data were pooled for statistical analysis.
The mean age of the included patients was 44.8 ± 19.8 years old; all were local ethnic Chinese residents. Fifty-three percent were male. Sixty-one cases (57%) had pre-existing epilepsy. Delay in treatment was recorded in 31 patients (29%) and refractory SE developed in 34 (32%). The most common aetiology was cerebrovascular disease (27%), followed by idiopathic (18%), metabolic derangement (16%) and anti-epileptic drug non-compliance (14%) (Fig. 1) . SE was secondary to an acute symptomatic event such as new onset stroke or meningitis in 46 (43%) patients. Seizure types consisted of generalised tonic-clonic in 81 patients (76%), partial in 18 (17%), non-convulsive in 5 (5%) and myoclonus in 3 (3%). Myoclonic seizures were secondary to post-hypoxic encephalopathy in all three patients in the study.
The mean duration of hospitalisation was 16.4 ± 20 days. Eighty-two patients (77%) required admission to the ICU, with a mean period of 3.6 ± 5.9 days, and 65 patients (61%) were ventilated with a mean duration 2.7 ± 5.6 days. Sixty-two patients (57%) made a full recovery, 28 (26%) had a deterioration in functional ability at discharge compared with pre-morbid and 17 (16%) had died. The most common residual deficit was cognitive impairment and persistent hemiparesis. Nine variables identified in the univariate analysis as significant variables were included in the multivariate model: older age, a prior history of epilepsy, non-convulsive and myoclonic seizures, SE due to cerebrovscular disease, CNS infection, tumour, alcohol and delay in treatment ( 
DISCUSSION
The importance of the underlying cause of SE in determining outcome is increasingly recognised; patients ideally should be categorised into good and poor prognostic groups for the purposes of clinical trials and treatment. A history of acute or remote cerebrovascular disease was the most common disorder causing SE in our study while cerebrovascular disease and CNS infection were associated with a higher risk of poor outcome. These two diagnoses have also been reported to carry a higher case fatality in a large population-based series from California 6 . Compared with previous reports, alcohol-related SE is not a common cause in this series which is probably due to the lower prevalence of alcohol use and dependence in Chinese communities; this may be one reason for the lower incidence of generalised convulsive SE in Asians 6 . Age is an important factor in the distribution of aetiology. In studies looking at older patients, strokes, tumours are more frequent while in children, febrile convulsions and CNS infections are more common. The percentage of idiopathic cases may vary depending on the thoroughness of investigation.
There are a number of limitations to the current series. The partly retrospective nature of this study may have introduced bias; errors in coding or diagnosis may have lead to under-ascertainment of cases. In particular, NCSE may be missed without a strong index of suspicion and easily accessible EEG. Generalised SE is, however, less likely to be missed or misdiagnosed by clinicians. We have tried to minimise underestimation by searching for cases of SE from different databases. Although this study was conducted at a single public hospital, in our locality the vast majority of patients with acute neurological emergencies are treated in government hospitals. Another limitation is the sample size, as reflected in the large confidence intervals in some of the variables; additional factors associated with poor outcome may be identified with a larger sample population.
SE is more common in the elderly and mortality is also higher in this age group [2] [3] [4] [5] [6] [18] [19] [20] [21] [22] . With the ageing of the population in China, the incidence of SE, as well as its complications is expected to rise. The range in reported fatality rates may be due to different patient populations under review; in studies reporting higher mortality rates, the mean age of patients with SE are higher. In our centre, overall 22% of patients had a drop in functional ability while the mortality was 16%, which is in keeping with experience from other studies and which underscores the severity of this condition. As with many clinical studies, we looked at mortality on discharge; a longer period of evaluation would be expected produce a higher figure. In the only long-term population-based survey of SE, Logroscino found that at 10 years the cumulative mortality rate of patients who survived the first 30 days was 43%, a three-fold increase compared with the general population 22 . From clinical and experimental data the longer the duration of SE, the more difficult it becomes to control seizures 4, 23 . Similarly, we found that delay in initiating treatment is associated with poor outcome. The results from this series highlights the importance of rapid diagnosis and treatment.
